Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Brainshuttle AD: A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7126209 Following Intravenous Infusion in Participants With Prodromal or Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]
A Phase 1/2 multiple ascending dose trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of RO7126209 (Brainsh…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices [NA]
This clinical trial update describes an ongoing study by Azienda Ospedaliera di Perugia aiming to profile Parkinson's disease molecularly us…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Digitally-enhanced, Decentralized, Multi-omics Observational Cohort
An observational cohort study that uses digital, decentralized, multi-omics approaches, sponsored by Greece 2021 Committee, is currently enr…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: 40 Hz Transcranial Alternating Current Stimulation for Inducing Gamma Oscillations [NA]
This trial update notes completion of a study evaluating 40 Hz transcranial alternating current stimulation to induce gamma oscillations in …
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Effects of Dance and Music Appreciation on Brain Health and Fitness in People at Risk for Alzheimer's Disease [NA]
A Wake Forest University Health Sciences study investigates whether dance and music appreciation can improve brain health and fitness in peo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Levetiracetam for Persons at Risk for Alzheimer's Disease [Phase 2]
This clinical trial update covers a Phase 2 study of levetiracetam for individuals at risk of Alzheimer's disease. The study is currently re…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: WeCareToFeedDysphagia to Reduce Care-partner Burden Full-scale RCT [NA]
The update indicates that the full-scale randomized trial WeCareToFeedDysphagia to Reduce Care-partner Burden is currently enrolling by invi…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease [EARLY_Phase 1]
Phase 1 study from Johns Hopkins is evaluating psilocybin for depressive symptoms in people with mild cognitive impairment or early Alzheime…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Assessment of Malnutrition in Hospitalized Patients: a Quasi Study
This clinical trial update describes a quasi-study assessing malnutrition in hospitalized patients, including those with COPD and Alzheimer'…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008) [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of MK-1167 in participants with Alzheimer's disease dementia; the study is cu…
-
EMA approval · 2026-03-13EMA Authorised: Vizamyl (flutemetamol (18F)) — GE Healthcare AS
EMA authorised Vizamyl (flutemetamol (18F)) for radionuclide PET imaging in adults being evaluated for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Decreasing Alzheimer's Risk Through oNline Choreographed Exercise - Down Syndrome [NA]
A completed trial evaluated whether an online choreographed exercise program reduces Alzheimer's risk in people with Down syndrome. Results …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Social-cognitive Functioning: Validation of a New Neuropsychological Test [NA]
A clinical trial update indicates ongoing recruitment for validating a new neuropsychological test of social-cognitive functioning. The stud…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease [Phase 2]
Phase 2 clinical trial is recruiting to evaluate an allopregnanolone regenerative therapeutic for mild Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study [Phase 1]
Phase 1 intramuscular trial of allopregnanolone as a regenerative therapy for early Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid [Phase 3]
This update covers the Phase 3 AHEAD 3-45 study evaluating lecanemab for preclinical and early preclinical Alzheimer's disease; the trial is…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Dementia Caregivers' Link to Assistance and Resources [NA]
A clinical trial sponsored by Visiting Nurse Service of New York is currently recruiting to study dementia caregivers' access to assistance …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Effects of Musical Intervention by a Therapist (IMT) on Falling Asleep and Behavioral Regulation in a Secure Care Unit (SCU) [NA]
This clinical trial entry describes a study on the effects of musical intervention by a therapist (IMT) on falling asleep and behavioral reg…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.
A newly listed clinical trial is exploring precision medicine approaches for diagnosing and treating Parkinson's disease and Alzheimer's dis…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Speech Pattern Evaluation and Analysis for Knowledge of AD
A recruiting clinical trial from the University of Wisconsin evaluating speech patterns related to Alzheimer's disease.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Adaptation of the Mini-Mental State Examination (MMSE) for the Reunion Island Population [NA]
A clinical trial update from Centre Hospitalier Universitaire de la Réunion describes adapting the Mini-Mental State Examination for use in …
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Learning Amyloid and Tau Results
Clinical trial update from University of Wisconsin studying amyloid and tau in Alzheimer disease; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: COGSCREEN II: Early Detection of Cognitive Impairment [NA]
This is a clinical trial update for COGSCREEN II, a study on early detection of cognitive impairment in Alzheimer's disease. It is currently…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Gamma Induction for Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating gamma induction as a potential therapy for Alzheimer's disease and mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: System-IGF-1 Pathway and Alzheimer's Disease
Completion of a clinical trial evaluating the System-IGF-1 pathway in Alzheimer's disease and mild cognitive impairment.